New Key Statistics Module, Z-Score and F-Score
NYSE:RDY Key Ratios
Market Cap $ M | 11,578.83 |
Enterprise Value $ M | 10,811.71 |
P/E(ttm) | 17.55 |
PE Ratio without NRI | 18.40 |
Forward PE Ratio | 20.12 |
Price/Book | 3.46 |
Price/Sales | 3.50 |
Price/Free Cash Flow | 54.33 |
Price/Owner Earnings | 19.94 |
Payout Ratio % | 0.13 |
Revenue (TTM) $ M | 3,367.00 |
EPS (TTM) $ | 4.03 |
Beneish M-Score | -2.41 |
10-y EBITDA Growth Rate % | 8.70 |
5-y EBITDA Growth Rate % | 23.00 |
y-y EBITDA Growth Rate % | 18.60 |
EV-to-EBIT | 12.40 |
EV-to-EBITDA | 10.32 |
PEG | 0.80 |
Shares Outstanding M | 166.53 |
Net Margin (%) | 19.96 |
Operating Margin % | 23.82 |
Pre-tax Margin (%) | 25.76 |
Quick Ratio | 1.92 |
Current Ratio | 2.59 |
ROA % (ttm) | 15.78 |
ROE % (ttm) | 21.77 |
ROIC % (ttm) | 22.15 |
Dividend Yield % | 0.70 |
Altman Z-Score | 7.34 |
RDY Number of Guru Trades
RDY Volume of Guru Trades
Gurus Latest Trades with NYSE:RDY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:RDY is held by these investors
Total 1
Dr Reddy's Laboratories Ltd Insider Transactions
No Available Data
News about NYSE:RDY
Total 0- 1